Philips and Spencer Health Solutions Expand Partnership to Europe

PhilipsBuilding on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced the expansion of their partnership to Europe.

Technological solutions can help patients and their caregivers to improve medication plan compliance. Medication adherence reduces hospitalization, emergency department use and doctor’s visits of patients and thereby lessens this burden on healthcare systems leading to lower healthcare costs [1,2]. Estimates suggest that non-adherence contributes to nearly 200,000 premature deaths in Europe and costs of EUR 125 billion annually in excess healthcare services for European Governments [2].

"As health systems work to better manage high risk and high-cost patient populations, medication adherence solutions can help to improve medication management and increase patient engagement," said Derek Ross, Business Leader Population Health Management at Philips. "Technological solutions can help our customers to improve medication adherence of their patients and to deliver better value-based care. We are excited to bring a user-friendly and patient-centric solution for medication adherence to Europe together with Spencer Health Solutions."

Already in use by patients taking multiple medications in the United States and Canada, the Spencer® Smart Hub is launching in selected markets in Europe including Austria, Belgium, Germany, Luxembourg, Netherlands and Switzerland, beginning with the Netherlands in the fourth quarter of 2019. The Spencer medication adherence solution is part of a portfolio of Philips solutions to support and remotely manage elderly and patients in their homes and connect them with their care providers when needed.

"Through our partnership with Philips we can now jointly introduce our medication adherence solution into the homes of patients across Europe," said Tom Rhoads, CEO of Spencer. "This expansion builds on our existing partnership in the U.S. which benefits care providers and patients by improving medication adherence. Our digital solution, that connects patients and care providers, supports the delivery of medicine and proactive care while driving down the costs of medical complications related to non-adherence."

The Spencer device offers a connected ecosystem: an in-home dispensing device providing pre-packaged unit dose medication, a connection to the pharmacy and an assist app for family and caregivers. Family and caregivers are notified and able to contact the patient, when the patient does not take medication. The platform has high rates of medication adherence and patient engagement in the U.S. A case study shows an average adherence rate for patients using Spencer greater than 95 percent, and an average patient response rate to health status questions presented with medication dispenses greater than 81 percent [3].

1. Roebuck, M.C. et al., Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs, 2011, Jan;30(1):91-99.
2. OECD (2018) Investing in medication adherence improves health outcomes and health system efficiency - Available at: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DELSA/HEA/WD/HWP(2018)2&docLanguage=En Last accessed: 13 September
3. Spencer whitepaper - https://spencerhealthsolutions.com/wp-content/uploads/2019/06/Whitepaper-6-19-19-FINAL-Published.pdf

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

About Spencer Health Solutions

Advancing research and healthcare from the home. Bring new treatments to market faster and at lower cost with the spencer® Smart Hub. Spencer Health Solutions, Inc.'s award-winning spencer® Smart Hub combines medication dispensing, telehealth and engagement so patients, their health care providers, and clinical research teams stay connected.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...